Osteoporosis treatment for high-risk women is cost-effective, with bisphosphonates providing the most benefit at the lowest cost.
Russel T. Burge, PhD
Advertisement
Articles by Russel T. Burge, PhD
Advertisement
Latest Updated Articles
- Therapies for Treatment of Osteoporosis in US Women: Cost-effectiveness and Budget Impact Considerations
Published: September 15th 2008 | Updated:
Advertisement
Advertisement
Trending on AJMC
1
FDA Approves Imlunestrant for ER+ and HER2-Negative Breast Cancer
2
In Primary Care–Oncology Collaboration, the Baton Goes Both Ways
3
FDA Expands Evinacumab-dgnb Approval for Children as Young as 1 Year With HoFH
4
Marathon Health, Medbridge Partner to Launch Integrated Virtual MSK Care Program
5
